The observed increase in MYC activity and ribosome biogenesis aligns with previous studies showing that MYC is a key regulator of ribosome biogenesis[42,43], and both processes are implicated in drug resistance in yeast and human cancers[31,44,45]. Here, MYC is linked to cancer.